imipenem, vancomycin, metronidazole) were investigated on the course of experimental colitis induced by trinitrobenzenesulphonic acid (TNB) in the rat. On day 7 and 21 after the induction of colitis, matched groups of control and antibiotic treated rats were subjected to colonic dialysis to measure eicosanoid release, and killed for morphological assessment of the colonic lesions (macro and microscopic scores). Stool samples were cultured. Selective antibiotic treatment against Gram positive, Gram negative or anaerobic bacteria had no effect on colonic lesion scores. By contrast, certain broad spectrum antibiotics (amoxicillinlclavulanic acid or the association of imipenem plus vancomycin) significantly reduced macro and microscopic scores. Rats receiving these antibiotics did not develop chronic colitis as shown by the virtual absence of colonic strictures, adhesions, fibrosis, and granulomas. On day 21 after TNB, the intracolonic release of prostaglandin E2, thromboxane B2, and leukotriene B4 was significantly higher in control than in antibiotic treated rats. Control stool cultures showed abundant colony forming units of both aerobic and anaerobic bacteria. Amoxicillin/clavulanic acid and imipenem plus vancomycin induced appreciable reductions in luminal bacteria. In conclusion, certain broad spectrum antibiotics prevent chronic colitis. The normal colonic flora seems to play an important pathogenetic part in the progression of inflammatory colonic lesions to chronicity. (Gut 1994; 35: 1090-1097)
The need for a reliable experimental model of inflammatory bowel disease has led to considerable attention being given in recent years to the trinitrobenzenesulphonic acid (TNB) model of intestinal inflammation in the rat. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] Inflammatory lesions in the distal colon that persist for up to five to six weeks can be induced by a single intracolonic dose of TNB dissolved in ethanol.2 Chronic colitis by TNB is characterised by large mucosal ulcerations and transmural inflammation with serosal involvement and adhesions to surrounding tissues. The inflammatory infiltrate consists of both polymorphonuclear and mononuclear cells with occasional granulomas. At high TNB doses, most animals develop colonic strictures that eventually result in voluminous dilatation of the proximal bowel with large chronic ulcers. Spare areas of normal mucosa, however, are seen in the vicinity of the lesions. Thus, the model shows some morphological features that resemble human Crohn's disease.
The mechanism by which TNB induces the lesions is not clear. 7. In all experiments, weight controls were performed on days 0, 3, and 7 after TNB. On day 7, the rats were given intracolonic dialysis, and they were then killed by cervical dislocation. The distal colon was removed, opened longitudinally, rinsed with physiological saline, and pinned out on synthetic cork. The lesions were assessed macroscopically and the whole piece was then fixed in a solution containing 2% formaldehyde and 1% glutaraldehyde for later histological examination.
Protocol B: effect of antimicrobials on the chronic stage of TNB colitis Sixty rats were included in this part of the study. The experiments consisted of a test group (n = 15) that received antibiotic treatment, and a matched control group (n = 15) that received vehicle. The following drugs were tested: amoxicillin (160 mg/kg per day) plus clavulanic acid (40 mg/kg per day) given twice daily by intracolonic enema in saline (controls received saline enemas twice daily); and imipenem (50 mg/kg per day) plus vancomycin (50 mg/kg per day), diluted in the drinking water. Treatment started three days before the induction of colitis and was continued up to day 7 after TNB. Thereafter, no treatment was given up to day 21, which was the end point of the experiments. The rats were then given intracolonic dialysis, and killed by cervical dislocation. Colons were exposed, scored macroscopically, and processed for histological assessment as above.
ASSESSMENT OF COLONIC LESIONS
The macroscopically visible damage was assessed with a stereomicroscope by two As Figure 1 shows, the way the antibiotic treatment was given was critical for a beneficial effect. The combination of imipenem with vancomycin acid was effective when given orally or by enema, whereas intraperitoneal injection resulted in no significant effect (Fig 1) . Both imipenem and vancomycin are poorly absorbed when given orally. Plasma concentrations of vancomycin were undetectable in four rats that received the drug by oral gavage. Therapeutic values of vancomycin could, however, be detected in plasma samples one hour after intraperitoneal injection of the drug (24 (7) p.g/ml), even though this method yielded no beneficial effect on the colitis. Therefore, the beneficial effect of these antimicrobial drugs on colonic inflammation is unrelated to plasma bioavailability. Appropriate antimicrobial concentration in the colonic lumen seems to be critical for achieving a colonic therapeutic effect.
When imipenem plus vancomycin treatment was started 24 hours after induction of colitis, rats showed on day 7 lower macroscopic (7X1 (08)) and histological (8-4 (0 5)) lesion scores than controls (9-8 (0 3)) and 9 7 (0 3), respectively, p<005). The effect was similar to that seen in rats pretreated with imipenem plus vancomycin (macroscopic score: 6-4 (07); histological score: 8-1 (05). By day 7, 3 of 15 rats had died in the control group, and 2 of 15 rats in each imipenem plus vancomycin group (pretreatment and post treatment groups). beyond day 7 in dilated bowel segments proximal to strictures. It is therefore interesting to note that ulceration scores were higher in controls than in antibiotic treated rats. No mortality was seen in amoxicillin/clavulanic acid treated rats, and one rat from the control group died.
By light microscopy, microgranulomas were found in 38% of the control rats whereas none of the rats with amoxicillin/clavulanic acid and only one rat in the imipenem plus vancomycin group showed microgranulomas (p<0 05, Fisher's exact test). Figure 4 shows the changes in body weight that occurred after induction of TNB colitis in control and in imipenem plus vancomycin treated rats. A net body weight loss was detected in every animal from the control group three days after the TNB challenge and continued during the acute stage of colitis peaking by day 7. In contrast, antibiotic treated animals did not experience any significant weight loss. During the chronic stage of colitis, rats from the control group gradually recovered their lost body weight but, as shown by Figure 4 , body weight gain remained significantly higher in antibiotic treated rats than in controls.
COLONIC RELEASE OF INFIAMMA'I'ORY

MEDIA'I'ORS
The release of inflammatory mediators by the colonic mucosa was measured in vivo by intracolonic dialysis. Figure 5 shows luminal eicosanoid release in controls and in rats treated orally with imipenem-vancomycin. Before the induction of colitis, a baseline luminal release of prostaglandin E, thromboxane B,, and leukotriene1 was detected in both experimental groups. By day 7 after TNB, luminal eicosanoid release had considerably increased in both groups of animals reflecting colonic inflammation. No significant differences between groups were apparent. By day 21 after TNB, however, luminal release of all three eicosanoids in antibiotic treated rats had decreased towards baseline values, whereas it remained significantly raised in control rats. These findings are consistent with our finding that during the chronic stage of TNB colitis inflammatory activity only persisted in control rats but not in imipenemvancomycin treated rats.
Similar results were obtained in rats treated with amoxicillin/clavulanic acid enemas.
On day 21, luminal eicosanoid release in amoxicillin/clavulanic acid rats had returned to baseline, while control rats showed considerable release of inflammatory mediators significantly above baseline values. Imipenem alone increased mortality. These findings suggested that the drugs were not primarily responsible for the anti-inflammatory effect, but that a broad spectrum bacterial decontamination was required to improve the colitis. The route of administration was critical to achieve a therapeutic effect. Non-absorbable antibiotics such as imipenem and vancomycin were effective when given orally or by enema, whereas intraperitoneal injections were not effective. Only appropriate intracolonic concentrations of the antimicrobial drugs were associated with the anti-inflammatory effect. Therapeutic plasma concentrations of the antimicrobials were irrelevant. Again, these findings preclude the possibility of an antiinflammatory effect of the drugs unrelated to their antibiotic activity.
MICROBIOLOGICAL STUDIES
Selective antimicrobial treatment against Gram negative bacilli (tobramycin), Gram positive enterococci (vancomycin) or anaerobic species (metronidazole) had no effect on the colonic lesion scores. The association of tobramycin and vancomycin was also ineffective. Imipenem, a drug active against a wide range of Gram negative and Gram positive species including some anaerobes, intensified the colonic lesions and increased mortality induced by TNB. Our microbiological studies showed that treatment with imipenem only induced overgrowth of Bacteroides spp, particularly Bacteroides vulgatus. These results suggest that superinfection with Bacteroides vulgatus may exacerbate colonic lesions induced by TNB. Our findings are in agreement with previous studies by Onderdonk et al,15 16 that extensively showed the implication of Bacteroides vulgatus in the pathogenesis of carrageenin induced colitis in the guinea pig. In contrast with our findings, however, these authors saw in the guinea pig model that pretreatment with metronidazole prevents the induction of colitis by carrageenin feeding. 17 The microbiological studies showed that treatment with imipenem plus vancomycin or amoxicillin/clavulanic acid significantly reduced the luminal content of bacteria species. In stool specimens from rats treated with imipenem plus vancomycin, aerobic and anaerobic bacteria were almost absent and had been replaced by overgrowth of Candida spp. Amoxicillin/clavulanic acid induced no important qualitative changes in the faecal flora, but reduced colony counts of anaerobes to 50% compared with controls. The fact that systemic antibiotics failed to prevent chronic inflammatory colitis suggests that dissemination of pathogens that could invade tissues is not a critical mechanism in the process of developing chronic lesions. Colitis induced by TNB does not evolve as a septic condition. Superinfection of TNB induced injury by normal flora, however, may play an important part, because when proliferation of the colonic flora is inhibited by appropriate intraluminal antibiotics a remarkable therapeutic action on colitis is achieved. Treatment with imipenem plus vancomycin was also effective when given 24 hours after the challenge with TNB, suggesting that the antibiotics enhanced repair mechanisms of established TNB induced lesions. Thus, commensal bacteria seem to be responsible for the chronicity of the inflammatory response to TNB. This sort of bacteria cannot cross epithelial barriers and spread beyond the injured areas, but they can proliferate on the surface of the lesions and hamper the resolution of the healing process. The precise mechanism by which they do so cannot be established from this study but our data clearly show that the presence of bacteria and their products perpetuates the inflammatory response. Perhaps, by sustaining the antigenic insult they stimulate the progression of the colitis towards chronicity.
The participation of luminal bacteria in the pathogenesis of other inflammatory conditions of the bowel has also been suggested in other animal models. Bacteria or bacterial products seem to be critical to the induction of mucosal ulcerations in the small bowel by indomethacin, as germ free rats develop minimal lesions18 19 and antibiotics decrease the severity of the ulcers.20 As mentioned, proliferation of anaerobes has been incriminated in the pathogenesis of experimental colitis by chronic feeding of sulphated polysaccharides such as carrageeninl4-17 or dextran sulphate.2' This study provides significant evidence that the normal colonic flora plays a key part in the progression of inflammatory colonic lesions to chronicity, and hence illuminates the potential relevance of this often overlooked factor in human disease.
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